Drug · DIN 02371766
MAR-RISPERIDONE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 17, 2013; first marketed April 17, 2013.
- Drug Identification Number (DIN)
- 02371766
- Company (DIN owner)
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 0.25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 7, 2011: NOC 12613Abbreviated New Drug Submission (ANDS) · New Manufacturer and Product Name
Other DINs named MAR-RISPERIDONE
- DIN 02371774 · Marketed
- DIN 02371782 · Marketed
- DIN 02371790 · Marketed
- DIN 02371804 · Marketed
- DIN 02371812 · Marketed